|Abstract:||This invention relates to low irritative ophthalmics containing the compound of the formula or salts thereof which are useful for treatment of anti-allergic eye diseases such as allergic conjunctivitis ##STR1##|
|Inventor(s):||Morita; Takakazu (Toyonaka, JP), Iso; Tadashi (Kawachinagano, JP), Kawashima; Youichi (Kyoto, JP), Hikida; Mitsushi (Takatsuki, JP)|
|Assignee:||Santen Pharmaceutical Co., Ltd. (Osaka, JP)|
Patent Claim Types:|
see list of patent claims
|Composition; Formulation; Compound; Dosage form; Use;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.